HK inno.N Corporation

About HK inno.N Corporation

HK inno.N is becoming a global No.1 pharmaceutical player in the global market by expanding exports and strengthening local business.A global pharmaceutical company that the world market watches Based on global sales and marketing competences that have been accumulated for years, we have rolled out the ethical drugs, active pharmaceutical ingredient (API), and Health & Beauty products across the globe. On the basis of new drug R&D for a range of success experiences and advance to global markets, we are expanding the exports to Japan, Southeast Asia, Central and South America, and Europe, and have directly made inroads into Vietnamese market, constructed sales network, and consolidated sales ...

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2020
Company types
Pharmaceutical company
Contact info
  • 239, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Korea, Republic Of

Products from HK inno.N Corporation (7)

  • Exone-R Tab. (Valsartan/Amlodipine/Rosuvastatin)

    Product Exone-R Tab. (Valsartan/Amlodipine/Rosuvastatin)

    Exone-R is a fixed-dose triple combination therapy for patients with hypertension and dyslipidemia. It combines Valsartan and Amlodipine to help control blood pressure, along with Rosuvastatin to manage cholesterol levels. By addressing both cardiovascular risk factors in a single tablet, Exone-R supports ...
  • Omap One Inj / Omap Plus One Inj (TPN)

    Product Omap One Inj / Omap Plus One Inj (TPN)

    Omap One Peri is a three-chamber peripheral parenteral nutrition solution designed for patients who cannot receive sufficient nutrition orally or enterally. It provides essential nutrients, including glucose, amino acids, and lipids, to support energy needs and nutritional balance. The product can be admin...
  • Tegoprazan

    Product Tegoprazan

    Tegoprazan is a novel patented Potassium-Competitive Acid Blocker (P-CAB) which alleviates the limitations of the historical Proton Pump Inhibitors (PPIs) and of other competing P-CABs. 

    Tegoprazan's competitive advantages have been demonstrated via Phase 3 clinical studies conducted in Korea a...
  • Atomet XR Tab. (Atorvastatin + Metformin)

    Product Atomet XR Tab. (Atorvastatin + Metformin)

    Fixed Dose Combination drug, indicated for Type2 Diabetes with Hyperlipidemia with Clinical trials phase Ⅰ & Ⅲ

  • Calmtop RTU Inj. (Irinotecan)
  • Closone Cap. (Clopidogrel + Aspirin)

    Product Closone Cap. (Clopidogrel + Aspirin)

    Fixed Dose Combination drug, indicated for Atherosclerosis, thromboembolism
  • Silenor Tab. (Doxepine)

    Product Silenor Tab. (Doxepine)

    Insomnia, Non-addictive and helps staying asleep longer